Roles of iron in neoplasia. Promotion, prevention, and therapy.
Research and clinical observations during the past six decades have shown that: 1. Iron promotes cancer cell growth; 2. Hosts attempt to withhold or withdraw iron from cancer cells; and 3. Iron is a factor in prevention and in therapy of neoplastic disease. Although normal and neoplastic cells have similar qualitative requirements for iron, the neoplastic cells have more flexibility in acquisition of the metal. Excessive iron levels in animals and humans are associated with enhanced neoplastic cell growth. In invaded hosts, cytokine-activated macrophages increase intracellular ferritin retention of the metal, scavenge iron in areas of tumor growth, and secrete reactive nitrogen intermediates to effect efflux of nonheme iron from tumor cells. Procedures associated with lowering host intake of excess iron can assist in prevention and in management of neoplastic disease. Chemical methods for prevention of iron assimilation by neoplastic cells are being developed in experimental and clinical protocols. The antineoplastic activity of a considerable variety of chemicals, as well as of radiation, is modulated by iron. The present article focuses on recent findings and suggests directions for further cancer-iron research.
Weinberg
E D
ED
Department of Biology and Program in Medical Sciences, Indiana University, Bloomington 47405.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D002455:Cell Division; D006801:Humans; D007501:Iron / Q000502:physiology*; D009369:Neoplasms / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control
D000903:Antibiotics, Antineoplastic; D007501:Iron